{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:15:10Z","timestamp":1790874910579,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejim.2025.106576","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:51:51Z","timestamp":1761972711000},"page":"106576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Multidisciplinary strategies and new technologies in the management of sarcoidosis"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-7866","authenticated-orcid":false,"given":"Claudio","family":"Tana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Drent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogugua Ndili","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol","family":"Bernardinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Moffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Isra\u00ebl Biet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejim.2025.106576_bib0001","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0002","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0003","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0004","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/07853890.2022.2063375","article-title":"Comorbidities of sarcoidosis","volume":"54","author":"Tana","year":"2022","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/cells11010059","article-title":"Clinical features, histopathology and differential diagnosis of sarcoidosis","volume":"11","author":"Tana","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ejim.2025.106576_bib0006","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(21)00311-8","article-title":"Misconceptions regarding symptoms of sarcoidosis","volume":"8","author":"Drent","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0007","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00408-019-00206-7","article-title":"The burden of sarcoidosis symptoms from a patient perspective","volume":"197","author":"Voortman","year":"2019","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.ejim.2025.106576_bib0008","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/joim.13629","article-title":"Sarcoidosis: epidemiology and clinical insights","volume":"293","author":"Rossides","year":"2023","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0009","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.chest.2020.05.561","article-title":"Mixed obstructive and restrictive ventilatory defect in sarcoidosis: a new phenotype?","volume":"158","author":"Obi","year":"2020","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.ejim.2025.106576_bib0010","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","article-title":"American Heart Association Heart F, Transplantation Committee of the Council on Clinical C, Council on C and Stroke N. Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ejim.2025.106576_bib0011","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3390\/jcm10091941","article-title":"Clinical features and diagnosis of cardiac sarcoidosis","volume":"10","author":"Tana","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0012","article-title":"Redefining cardiac sarcoidosis with advanced imaging and therapeutic strategies","author":"Tana","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0013","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cld.1055","article-title":"Gastrointestinal and hepatic sarcoidosis: a review article","volume":"17","author":"Shah","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0014","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCP.0b013e3283541626","article-title":"Therapeutic approach of hepatic sarcoidosis","volume":"18","author":"Cremers","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103207","article-title":"Kidney manifestations of sarcoidosis","volume":"149","author":"Bonella","year":"2024","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccm.2023.08.005","article-title":"Neurosarcoidosis and neurologic complications of sarcoidosis treatment","volume":"45","author":"Voortman","year":"2024","journal-title":"Clin Chest Med"},{"issue":"7","key":"10.1016\/j.ejim.2025.106576_bib0017","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/07853890.2015.1093164","article-title":"Challenges in the diagnosis and treatment of neurosarcoidosis","volume":"47","author":"Tana","year":"2015","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0018","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2445191","article-title":"Neuropsychiatric manifestations of sarcoidosis","volume":"57","author":"Tana","year":"2025","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.ejim.2025.106576_bib0019","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nmd.2022.05.012","article-title":"Clinical characteristics and outcome in muscular sarcoidosis: a retrospective cohort study and literature review","volume":"32","author":"Ten Dam","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/039463201402700302","article-title":"The \"mystery\" of cutaneous sarcoidosis: facts and controversies","volume":"27","author":"Tchernev","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"11","key":"10.1016\/j.ejim.2025.106576_bib0021","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/bjophthalmol-2020-317354","article-title":"Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis","volume":"105","author":"Takase","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1056\/NEJMicm2501706","article-title":"L\u00f6fgren's Syndrome","volume":"393","author":"Hassan","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00408-024-00761-8","article-title":"A snapshot of United States sarcoidosis patients and their perceived disease impact: results of the sarcoidosis research institute survey","volume":"203","author":"Obi","year":"2025","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0024","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"Drent","year":"2012","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ejim.2025.106576_bib0025","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/diagnostics11061089","article-title":"Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes","volume":"11","author":"Saketkoo","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.ejim.2025.106576_bib0026","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S2213-2600(24)00297-2","article-title":"Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis","volume":"12","author":"Drent","year":"2024","journal-title":"The Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0027","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","article-title":"Phenotyping sarcoidosis from a pulmonary perspective","volume":"177","author":"Prasse","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0028","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.chest.2023.10.021","article-title":"High-resolution CT scan fibrotic patterns in stage IV pulmonary sarcoidosis: impact on pulmonary function and survival","volume":"165","author":"Obi","year":"2024","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0029","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s12350-022-03129-8","article-title":"Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: meta-analysis and systematic review","volume":"30","author":"Adhaduk","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0030","first-page":"307","article-title":"Contrast-enhanced cardiac Magnetic resonance: distinction between cardiac sarcoidosis and infarction scar","volume":"34","author":"Smedema","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"9","key":"10.1016\/j.ejim.2025.106576_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0032","first-page":"1","article-title":"18F-FDG PET-CT imaging in sarcoidosis. Molecular mechanisms and application","volume":"38","author":"Tana","year":"2024","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.ejim.2025.106576_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1286684","article-title":"Assessment of treatment response in cardiac sarcoidosis based on myocardial 18F-FDG uptake","volume":"14","author":"Frischknecht","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0034","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MCP.0000000000000892","article-title":"The role of PET in the management of sarcoidosis","volume":"28","author":"Vender","year":"2022","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2214\/ajr.182.1.1820015","article-title":"Imaging manifestations of abdominal sarcoidosis","volume":"182","author":"Warshauer","year":"2004","journal-title":"Am J Roentgenol"},{"issue":"9","key":"10.1016\/j.ejim.2025.106576_bib0036","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/jcm9093028","article-title":"CT findings in pulmonary and abdominal sarcoidosis. Implications for diagnosis and classification","volume":"9","author":"Tana","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0037","first-page":"1","article-title":"Ultrasound imaging of abdominal sarcoidosis: state of the art","volume":"7","author":"Tana","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.ejim.2025.106576_bib0038","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/926203","article-title":"Hepatosplenic sarcoidosis: contrast-enhanced ultrasound findings and implications for clinical practice","volume":"2014","author":"Tana","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejim.2025.106576_bib0039","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00408-015-9826-3","article-title":"Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study","volume":"194","author":"Ungprasert","year":"2016","journal-title":"Lung"},{"issue":"10","key":"10.1016\/j.ejim.2025.106576_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223897","article-title":"Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis","volume":"14","author":"Eurelings","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejim.2025.106576_bib0042","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0043","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MCP.0000000000000906","article-title":"Hit-hard and early versus step-up treatment in severe sarcoidosis","volume":"28","author":"Vorselaars","year":"2022","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0044","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfac227","article-title":"GSF French Sarcoidosis Group. Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trial","volume":"38","author":"Mahevas","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00198-2023","article-title":"High-dose (40\u2005mg) versus low-dose (20\u2005mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial)","volume":"62","author":"Dhooria","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2025.106576_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105936","article-title":"Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis","volume":"165","author":"Vis","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0047","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0048","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s11739-023-03314-8","article-title":"Cardiovascular risk in rare diseases: a prognostic stratification model in a cohort of sarcoidosis patients","volume":"18","author":"Rizzi","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0049","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/jcm13051250","article-title":"Clinical pharmacology in sarcoidosis: how to use and monitor sarcoidosis medications","volume":"13","author":"Kwon","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa2501443","article-title":"PREDMETH Collaborators. First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate","volume":"393","author":"Kahlmann","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0051","doi-asserted-by":"crossref","DOI":"10.1136\/thorax-2025-223014","article-title":"Systematic review and meta-analysis of the efficacy of biologic and targeted synthetic therapies in sarcoidosis","author":"Bechman","year":"2025","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0052","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12931-022-01971-5","article-title":"Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis","volume":"23","author":"Sakkat","year":"2022","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0053","first-page":"218","article-title":"TNF alpha inhibitors in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"23","author":"Mahmood","year":"2024","journal-title":"Crit Pathw Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0054","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200429","article-title":"Consensus recommendations for the management of neurosarcoidosis: a Delphi survey of experts across the United States","volume":"15","author":"Manzano","year":"2025","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0055","first-page":"46","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0056","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0057","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0058","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.chest.2022.10.037","article-title":"Efzofitimod for the treatment of pulmonary sarcoidosis","volume":"163","author":"Culver","year":"2023","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0059","doi-asserted-by":"crossref","first-page":"00536","DOI":"10.1183\/23120541.00536-2024","article-title":"Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis","volume":"11","author":"Obi","year":"2025","journal-title":"ERJ Open Res"},{"issue":"18","key":"10.1016\/j.ejim.2025.106576_bib0060","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"INBUILD Trial investigators. Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0061","article-title":"Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial","volume":"8","author":"Atkins","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.ejim.2025.106576_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108126","article-title":"Durable remission of cardiac sarcoidosis following discontinuation of methotrexate: a prospective cohort study","volume":"243","author":"Alipour","year":"2025","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0063","doi-asserted-by":"crossref","first-page":"152\u201168","DOI":"10.1016\/j.chest.2021.07.2166","article-title":"National temporal trends in hospitalization and inpatient mortality in patients with pulmonary sarcoidosis in the United States between 2007 and 2018","volume":"161","author":"Alqalyoobi","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2025.106576_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2023.100037","article-title":"Reasons for hospitalization and all-cause mortality for adults with sarcoidosis","volume":"9","author":"Manansala","year":"2023","journal-title":"Am J Med Open"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0065","doi-asserted-by":"crossref","first-page":"164\u201171","DOI":"10.1016\/j.chest.2024.06.3839","article-title":"Sarcoidosis and emergency hospitalization","volume":"167","author":"Gazengel","year":"2025","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0066","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/diagnostics14040395","article-title":"High-risk sarcoidosis: a focus on pulmonary, cardiac, hepatic and renal advanced diseases, as well as on calcium metabolism abnormalities","volume":"14","author":"Isra\u00ebl-Biet","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.ejim.2025.106576_bib0067","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Uzunhan","year":"2017","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ejim.2025.106576_bib0068","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3390\/jcm13072054","article-title":"Sarcoidosis-associated pulmonary hypertension","volume":"13","author":"Isra\u00ebl-Biet","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0069","article-title":"Renal replacement therapy in sarcoidosis","volume":"9","author":"Calatroni","year":"2022","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0070","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03358-2020","article-title":"Lung transplantation for sarcoidosis: outcome and prognostic factors","volume":"58","author":"Le Pavec","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0071","doi-asserted-by":"crossref","first-page":"125\u201140","DOI":"10.1007\/s00392-021-01920-0","article-title":"Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis","volume":"111","author":"Bobbio","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ejim.2025.106576_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101442","article-title":"Satisfactory outcomes in orthotopic liver transplantation for hepatic sarcoidosis: the UK experience","volume":"68","author":"Sinharay","year":"2021","journal-title":"Transpl Immunol"},{"issue":"6","key":"10.1016\/j.ejim.2025.106576_bib0073","doi-asserted-by":"crossref","first-page":"534\u201144","DOI":"10.1016\/j.amjmed.2023.02.014","article-title":"The management of sarcoidosis in the 2020s by the primary care physician","volume":"136","author":"Judson","year":"2023","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0074","doi-asserted-by":"crossref","DOI":"10.1080\/13814788.2024.2418307","article-title":"Navigating sarcoidosis: recognizing, managing, and supporting patients in primary care","volume":"30","author":"Drent","year":"2024","journal-title":"Eur J Gen Pract"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13023-024-03152-7","article-title":"Diagnostic delay of sarcoidosis: an integrated systematic review","volume":"19","author":"Namsrai","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0076","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00028-2021","article-title":"Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids","volume":"7","author":"Entrop","year":"2021","journal-title":"ERJ Open Res"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0077","first-page":"468\u201177","article-title":"Drug-induced comorbidities in patients with sarcoidosis","volume":"28","author":"Drent","year":"2022","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0078","first-page":"87\u201198","article-title":"Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy","volume":"37","author":"Syed","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ejim.2025.106576_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107483","article-title":"Cough monitoring for pulmonary sarcoidosis","volume":"221","author":"Judson","year":"2024","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.ejim.2025.106576_bib0080","doi-asserted-by":"crossref","first-page":"1832\u20118","DOI":"10.1513\/AnnalsATS.202011-1467OC","article-title":"Barriers to care among patients with sarcoidosis: a qualitative study","volume":"18","author":"Harper","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0081","article-title":"Tackling health care disparities: how to build a sarcoidosis center","volume":"39","author":"Kron","year":"2022","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"9","key":"10.1016\/j.ejim.2025.106576_bib0082","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1513\/AnnalsATS.202412-1294RL","article-title":"Working together in sarcoidosis: experience and impact of a formalized multidisciplinary discussion","volume":"22","author":"Sharp","year":"2025","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0083","first-page":"115","article-title":"What comorbidities accompany sarcoidosis? A large cohort (n=1779) patients analysis","volume":"32","author":"Martusewicz-Boros","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0084","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/crj.12398","article-title":"The influence of comorbidities on mortality in sarcoidosis: a observational prospective cohort study","volume":"11","author":"Nowi\u0144ski","year":"2017","journal-title":"Clin Resp J"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ccm.2015.08.013","article-title":"Consequences of sarcoidosis","volume":"36","author":"Drent","year":"2015","journal-title":"Clin Chest Med"},{"issue":"7","key":"10.1016\/j.ejim.2025.106576_bib0086","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.4187\/respcare.02080","article-title":"Factors associated with fatigue in sarcoidosis","volume":"59","author":"Fleischer","year":"2014","journal-title":"Respir Care"},{"key":"10.1016\/j.ejim.2025.106576_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107432","article-title":"Pulmonary rehabilitation in sarcoidosis: a systematic review and meta-analysis","volume":"219","author":"Alsina-Restoy","year":"2023","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0088","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCP.0000000000000798","article-title":"Genetics in sarcoidosis","volume":"27","author":"Spagnolo","year":"2021","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.106576_bib0089","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41579-022-00821-x","article-title":"The dynamic lung microbiome in health and disease","volume":"21","author":"Natalini","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/rccm.201705-0891OC","article-title":"Microbial lineages in sarcoidosis. A meta-genomic analysis tailored for low\u2013microbial content samples","volume":"197","author":"Clarke","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0091","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70328","article-title":"Metagenomic analysis of lung microbiome in patients with interstitial lung diseases and sarcoidosis: an experimental study","volume":"8","author":"Takeuchi","year":"2025","journal-title":"Health Sci Rep"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0092","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00316.2023","article-title":"The role of the host-microbiome and metabolomics in sarcoidosis","volume":"325","author":"Kim","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0093","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MCP.0000000000001102","article-title":"Big data in sarcoidosis","volume":"30","author":"Rivera","year":"2024","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101062","article-title":"Design and rationale of a pilot randomized clinical trial investigating the use of a mHealth app for sarcoidosis-associated fatigue","volume":"32","author":"Chandler","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-2600(22)00387-3","article-title":"Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial","volume":"11","author":"Kahlmann","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.106576_bib0096","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/jpm10030097","article-title":"Benefit of wearing an activity tracker in sarcoidosis","volume":"22","author":"Drent","year":"2020","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0097","first-page":"14","article-title":"Perceptions of the fatigue experience and a breathing awareness meditation-integrated mHealth App for fatigue and stress in patients with sarcoidosis","volume":"11","author":"Christon","year":"2023","journal-title":"Fatigue"},{"issue":"8","key":"10.1016\/j.ejim.2025.106576_bib0098","doi-asserted-by":"crossref","first-page":"e3833","DOI":"10.2196\/38331","article-title":"Quality of life and physical activity in 629 individuals with sarcoidosis: prospective, cross-sectional study using smartphones (Sarcoidosis App)","volume":"10","author":"Chu","year":"2022","journal-title":"JMIR Mhealth Uhealth"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0099","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00371-2019","article-title":"Radiomic measures from chest high-resolution computed tomography associated with lung function in sarcoidosis","volume":"54","author":"Ryan","year":"2019","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ejim.2025.106576_bib0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2213-2600(18)30286-8","article-title":"Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study","volume":"6","author":"Walsh","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106576_bib0101","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ejim.2025.106576_bib0102","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00408-023-00641-7","article-title":"current applications of artificial intelligence in sarcoidosis","volume":"201","author":"Lew","year":"2023","journal-title":"Lung"},{"issue":"14","key":"10.1016\/j.ejim.2025.106576_bib0103","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton","year":"2020","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.ejim.2025.106576_bib0105","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/COPD.S319753","article-title":"Role of a digital clinical decision-support system in general practitioners' management of COPD in Norway","volume":"16","author":"Vijayakumar","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0106","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106576_bib0107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41591-018-0272-7","article-title":"Privacy in the age of medical big data","volume":"25","author":"Price","year":"2019","journal-title":"Nat Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:21:24Z","timestamp":1781911284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525004534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":107,"alternative-id":["S0953620525004534"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106576","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary strategies and new technologies in the management of sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106576"}}